Stock Events

Stock Events

NKGen Biotech 

$0.000300
23
+$0.00+0% Tuesday 13:52

Statistics

Day High
0.0012
Day Low
0.0012
52W High
0.0012
52W Low
0.0003
Volume
100
Avg. Volume
-
Mkt Cap
39,180.6
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
0Revenue
-44.29MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NKGNW. It's not an investment recommendation.
Apple
4
AAPL
Tesla
4
TSLA
Amazon
4
AMZN
Broadcom
4
AVGO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap292.35B
Novartis offers CAR-T cell therapies, competing in the broader cell therapy market against NKGen's NK cell therapies.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences, through its acquisition of Kite Pharma, competes in the cell therapy space for cancer, similar to NKGen Biotech.
Allogene Therapeutics
ALLO
Mkt Cap697.89M
Allogene Therapeutics is focused on allogeneic CAR-T therapies, which are in the same therapeutic category as NKGen's work with NK cells.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is engaged in gene editing to develop cancer therapies, indirectly competing with NKGen by targeting similar indications with a different technology.
Fate Therapeutics
FATE
Mkt Cap291.16M
Fate Therapeutics is developing programmed cellular immunotherapies, including NK and T-cell therapies, making them a direct competitor.

About

Established in 2021, Graf Acquisition Corp. IV is based in The Woodlands, Texas. This company currently conducts no major business operations; instead, its principal objective is to complete a strategic combination, such as a merger, acquisition of assets, stock exchange, or reorganization, with one or more existing businesses.
Show more...
CEO
Paul Y. Song
Employees
63
Country
United States
ISIN
US65488A1198

Listings

OTC Link
US
NKGNW
OTC Link
US
NKGN

0 Comments

Share your thoughts

FAQ

What is NKGen Biotech stock price today?▼
The current price of NKGNW is $0.00 USD — it has increased by +0% in the past 24 hours. Watch NKGen Biotech stock price performance more closely on the chart.
What is NKGen Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange NKGen Biotech stocks are traded under the ticker NKGNW.
What is NKGen Biotech market cap?▼
Today NKGen Biotech has the market capitalization of 39,180.6
What is NKGen Biotech revenue for the last year?▼
NKGen Biotech revenue for the last year amounts to 0 USD.
What is NKGen Biotech net income for the last year?▼
NKGNW net income for the last year is -44.29M USD.
How many employees does NKGen Biotech have?▼
As of September 05, 2026, the company has 63 employees.
In which sector is NKGen Biotech located?▼
NKGen Biotech operates in the Health & Wellness sector.
When did NKGen Biotech complete a stock split?▼
NKGen Biotech has not had any recent stock splits.
Where is NKGen Biotech headquartered?▼
NKGen Biotech is headquartered in Santa Ana, United States.